SCIENTIFIC PROGRAM

DAY BY DAY

DAY 1 - Wednesday June 15th

PRE CONGRESS COURSES

PRE COURSE 1 - NEONATAL STABILIZATION AND RESUSCITATION

GENERAL INFORMATION

HALF-DAY COURSE

TYPE practical and theoretical

LEVEL: Basic/Intermediate level

TARGET (OB/GYN/NEON): NEONATOLOGY and midwives/obstetricians

Coordinator: Liljana Kornhauser (Slovenia)

T. M. Berger (Switzerland) Fetal physiology and pathophysiological aspects of fetal / neonatal resuscitation

J. Wyllie (UK) Changes in neonatal resuscitation - an overview of history and recent advances

E. Chandraharan (UK) In utero resuscitation and stabilization

Angela Kribs (Germany) Concept of minimal handling in the delivery room

R.J. Abraham (UK) Ex-utero intrapartum treatment (EXIT) procedure

M. Vento (Spain) Oxygen in the delivery room

G. Lista (Italy) Delivery room stabilization of preterm infants with RDS

M. Ruedinger (Germany) Neonatal assessment in the delivery room - TEST-Apgar

K. F. LipperT (Denmark) Ethical dilemmas in fetal / neonatal resuscitation

PRE COURSE 2 - MATERNAL AND NEONATAL TRANSPORT

GENERAL INFORMATION

FULL DAY

TYPE: theoretical

LEVEL: Expert level

TARGET: Ob/Gyn/Neon

Coordinators: Irene Cetin (Italy), Magdalena Rutkowska (Poland)

P. Vergani (Italy) Levels of maternal care and maternal transport

Irene Cetin (Italy) Indications and controindications for acute maternal transport

L. Zimmermann (The Netherlands) Indications for acute transport of a term neonate

Marzanna Resko-Zachara (Poland) Congenital fetal malformations- the importance of in utero transport

J. Mazela (Poland) When and how to transfer a preterm baby with RDS?

V. Carnielli (Italy) Protecting the lung

L. Ramenghi (Italy) The encephalopatic but not necessarily asphyxiated baby: criteria for transport -

D. Ivanov (Russia) Neonatal monitoring in long distance aviation transport in life-threatening cases

M. Brendhal (Denmark) Specific training and expertise for neonatal transport

PRE COURSE 3 – MORNING - PHYSIOLOGY AND ASSESSMENT OF MATERNAL CARDIOVASCULAR

FUNCTION INTERNATIONAL WORKING GROUP ON MATERNAL HEMODYNAMICS

GENERAL INFORMATION

LEVEL: Basic/Intermediate level

TARGET: OB/GYN

Coordinator: C. Lees (UK)

09.00 C. Lees (UK) Introduction

09.10 H. Valensise (Italy) The maternal heart & arterial system

09.40 Wilkinson How do we assess the arterial system?

10.10 J. Cockroft How do we measure cardiac output?

10.40 Pause

11.00 W. Gyselaers (Belgium) Physiology and assessment of venous hemodynamics

11.30 M. Spaanderman (The Netherlands) Physiology and assessement of plasma volume

12.00 C. Lees (UK) Early pregnancy changes in cardiovascular function

12.30 Closure

PRE COURSE 3 - AFTERNOON - MATERNAL HEMODYNAMICS BEFORE/DURING

GESTATIONAL HYPERTENSIVE DISEASE

GENERAL INFORMATION

LEVEL: Advanced/Expert level

Coordinator: W. Gyselaers (Belgium)

14.00 W. Gyselaers (Belgium) Introduction

14.10 E. Ferrazzi (Italy) Evidence for two phenotypes of preeclampsia

14.40 H. Valensise (Italy) How does the heart change in GHD?

15.10 W. Gyselaers (Belgium) Venous hemodynamic dysfunction in GHD

15.40 Pause

16.00 A. Khalil Can we use arterial function to screen for PE at 12 weeks?

16.30 B. Thilaganathan Cardiac diastolic dysfunction, fetal growth and the placenta: an

integrated model

17.00 h: H. Duvekot Long term clinical implications of GHD

17.30 h: Closure

PRE COURSE 4 - MORNING: BASIC OBSTETRIC MANEUVERS

GENERAL INFORMATION

TYPE (practical or theoretical): Practical with mannikins

LEVEL: Advanced/Expert level

TARGET (OB/GYN/NEON): OB/GYN

NUMBER OF ATTENDEES: 16

Coordinator: S. Datta, United Kingdom –

Faculty: Isis Amer-Wahlin – Sweden, P. Antonazzo, Italy, Diogo Ayres de Campos, Portugal

Vaginal assisted delivery

Shoulder Dystocia

Breech Delivery

PRE COURSE 4 - AFTERNOON – FIGO INTRAPARTUM FETAL MONITORING COURSE

(organized by the EAPM Working group on intrapartum fetal monitoring)

GENERAL INFORMATION

TYPE (practical or theoretical): THEORETICAL+PRACTICAL

LEVEL: Basic/Intermediate

TARGET (OB/GYN/NEON): OB/GYN/MIDWIVES

Coordinator: D. Ayres-de-Campos (Portugal)

14:00-14:10 D. Ayres-de-Campos (Portugal) Introduction

14:10-14:35 B. Yli (Norway) Pathophysiology of fetal oxygenation during labour

14:35-14:55 E.Roth (France) Intermittent auscultation

14:55-15:20 Susanna Timonen (Finland) Cardiotocography

15:20-15:45 Isis Amer-Wahlin (Sweden) Adjunctive technologies

15:45-16:00 Break

16:00-18:00 C. Vaissiére (France); Tullia Todros (Italy) Case discussion

PRE COURSE 5 - DIABETES AND PREGNANCY WORKING GROUP

Chairmen of the EAPM Diabetes and Pregnancy Working Group:

M. Hod (Israel); U. Simeoni (Switzerland)

Session 1 Challenges in GDM Diagnosis and Solutions

Chairmen; Moshe Hod, Israel & Umberto Simeoni, Switzerland

0900-0910

Setting the scene ; Towards a Global Acceptance of GDM management – it

all started at the EAPM

Umberto Simeoni, Switzerland , EAPM President and

Moshe Hod, Israel, FIGO GDM Initiative Working Group Chairman, EAPM

President Elect

0910-0930

Setting the scene ; Facing the Non Communicable Diseases (NCD) Global

Epidemic – The battle of prevention starts in utero

Luis Cabero Roura, Spain

0930-0950 Diagnosis of GDM: The dispute

Gerard Visser, The Netherlands , Past President EAPM

0950-1010

Screening and diagnosis of Gestational Diabetes: Worldwide Scenario – The

voice of IADPSG

Fidelma Dunn , UK, President IADPSG

1010-1030

Screening and diagnosis of Gestational Diabetes: The European Scenario – The

voice of IADPSG

Tahir Mahmood, UK, President EBCOG

1030-1050 Implementing GDM diagnosis in a low resourced country – The Indian solution

Hema Divakar, India

1050-1110

Implementing GDM diagnosis in a high resourced country – The Italian

experience

Federico Mecacci, Italy

1110-1130 Is screening and integrated care for GDM cost effective?

Anil Kapur, India, Chairman of the Board WDF

1130-1150

The Global solution - The FIGO Initiative on GDM

Moshe Hod, Israel, FIGO GDM Initiative Working Group Chairman, EAPM

President Elect

1150-1230 Panel Discussion

Lunch 12:30 -13:30

Session 2 GDM Management

Chairmen; Gian Carlo Di Renzo , Italy & Gerard Visser, The Netherlands

1330-1350 Challenges in Maternal Fetal Medicine – How to get the Best Practice Advice

Gian Carlo Di Renzo , Italy ,FIGO Best Practice Working Group Chairman

1350-1410 Think Nutrition First – The FIGO guidelines on maternal nutrition

Mark Hanson, (UK)

1410-1430 Pharmacological Management of Diabetic Pregnancy – The New Insulins

Peter Damm, Denmark

1430-1450

Pharmacological Management of Diabetic Pregnancy – The Oral

Hypoglycemic Agents

Harold De Valk, The Netherlands

1450-1510 Management of Diabetic Pregnancy – The new technologies

Yariv Yogev , Israel

1510-1530

Intensified surveillance in DIP – evidence and problems

Diogo Ayres de Campos, Portugal, FIGO Ante natal assessment Working

Group Chairman

1530-1550 Can we diagnose all congenital anomalies in DIP

Yves Ville , France

1550-1610 Diabetic Pregnancy and DOHAD

Umberto Simeoni, Switzerland , EAPM President

1610-1630 Panel Discussion

PRE COURSE 6 – MORNING - FIRST TRIMESTER SCREENING FOR ADVERSE PREGNANCY

OUTCOMES (Basic – L Poon/O Kagan)

09:30 – 10:00 O. Kagan (Germany) Screening for aneuploidies - Measurement of fetal nuchal translucency

10:00 – 10:30 O. Kagan (Germany) Screening for aneuploidies - Measurement of additional markers – nasal

bone, tricuspid regurgitation, ductus venosus

10:30 – 11:00 Leona Poon (UK) Screening for preeclampsia and fetal growth restriction

11:00 – 11:30 Leona Poon (UK) Screening for fetal macrosomia and maternal gestational diabetes

11:30 – 12:00 TBD Screening for spontaneous preterm birth TBD

PRE COURSE 6 – AFTERNOON - FIRST TRIMESTER SCREENING FOR ADVERSE PREGNANCY

OUTCOMES (Intermediate/advanced –K Nicolaides/L Poon)

GENERAL INFORMATION

LEVEL: INTERMEDIATE/ADVANCED

14:00 – 14:20 K. Nicolaides (UK) Inverting the pyramid of pregnancy care

14:20 – 15:00 R. Chaoui (Germany) Screening for fetal anomalies

15:00 – 15:30 K. Nicolaides (UK) Contingent screening for aneuploidies – Use of cell free DNA testing

15:30 – 16:00 Leona Poon (UK) Contingent screening for preeclampsia and fetal growth restriction

PRE COURSE 7 - PERINATAL INFECTIONS

Coordinators: E. Herting (Germany); R. Romero (USA)

Moderator: E. Herting (Germany)

9:00 E. Herting (Germany) Welcome/Introduction

9:15 E. Herting (Germany) Group B streptococci (GBS): A problem that can only be solved in

close cooperation between obstetrics and neonatology!

9:45 C. Härtel (Germany) Nosocomial infections: Are we really prepared for the next outbreak in

perinatology?

10:15 C. Caspar (France /Sweden) Viral infections in pregnancy: Importance for mothers and newborns

10.45 - 11.15h Break

Moderator: Roberto Romero

11:15 Orlikowsky (Germany) Vaccinations: Important for mothers and newborns?

11:45 R. Romero (USA) Chorioamnionitis: The maternal side of the story

12:15 B. Kramer (The Netherlands) Chorioamnionitis: The neonatal side of the story

12:45 R. Romero (USA) Wrap up, discussion

13:00 end of the workshop

PRE COURSE 8 - MULTIPLE PREGNANCY

Coordinator: A. Malamitsi- Puchner (Greece) – Kypros Nicolaides (UK)

GENERAL INFORMATION

LEVEL: Intermediate/Advanced

Morning

9:00-9:15 A. Malamitsi-Puchner (Greece) Brief historical introduction:Twins in Ancient Greece

9:15-9:45 I. Blickstein (Israel) Maternal and Gestational Problems in Multiple Pregnancy

9:45-10:15 K. Nicolaides (UK) TTTS, TAPS, sIUGR: Diagnosis and Manangement

10:15-10:45 E. Lopriore (The Netherlands) Neonatal problems in Multiple (twin) Pregnancy, particularly after

interventions for TTTS, TAPS etc:

10:45-11-15 Break

11:15-11:45 D.Boomsma (The Netherlands) Problems later in life. Findings from Twin Registries

11:45-12:15 T. Spector (UK) Epigenetics explaining the differences between monochorionic twins

PRE COURSES 9 - EVALUATING BRAIN FUNCTION IN HIGH-RISK NEWBORNS

GENERAL INFORMATION

LEVEL: Intermediate/Advanced

Petra Huppi (Switzerland) MRI - biomarkers of brain injury and resilience

Linda de Vries (Netherlands) MRI - features associated with normal and abnormal outcomes

Lena Hellström-Westas (Sweden) aEEG and EEG for prediction of outcome

F. van Bel/P.Lemmers/G.Naulers NIRS for predicting outcome in high-risk babies

D. Murray/M. Keller Biomarkers

A. Bos Neurological examination and spontaneous movements

E. Gratacos (Spain) Value of fetal MRI)?

CONGRESS

EVENING OPENING SESSION

”Opening lecture on Wednesday: "How to run a department with 65.000 deliveries and 20.000 neonatology

admissions" Dr. Thang (Vietnam)

TBD - Diana Bianchi (Italy)

DAY 2 - Thursday June 16th

8.00-8.55 4 parallel rooms - oral presentation sessions

9.00-9.30 Key note lecture

Donna Ferriero (USA)

Perinatal brain injury – mechanism and possibilities for neuroprotection

9.30-10.30 Plenary

PLM8) MATERNAL OBESITY AND METABOLIC SYNDROME

Irene Cetin (Italy) Placental function and fetal growth in maternal obesity

J, Stupin (Germany) Perinatal programming of obesity

S, Johansson (Sweden) Maternal obesity and infant outcomes

10.30-11.00 COFFEE BREAK AND POSTER VIEWING

11.00-12.30: parallel 1

NEONATAL INFECTIONS

R.M. van Elburg (The Netherlands) Neonatal infections and long-term outcomes

R. Kornelisse (The Netherlands) Prevention of hospital acquired infections

H. Varendi (Estonia) Optimal doses of antibiotics?

C. P. Speer (Germany) Ureaplasma species and newborn morbidities

P. Manzoni (Italy) Management of Candida infections in preterm infants

C. Casper (France) CMV infection in preterm infants

11.00-12.30: parallel 2

THUR PAR-M1) SYMPOSIUM FETAL ALCOHOL SPECTRUM DISORDERS: PREVENTION AND MANAGEMENT

R. Mukerjee (UK) Fetal Alcohol Spectrum Disorders is it something we should be more aware of

S. Roozen (The Netherlands) Alcohol consumption during pregnancy: worldwide prevalence of Fetal Alcohol

D. Townsend (The Netherlands) Legal and ethical questions posed by Fetal Alcohol Spectrum Disorders Olivier

L. O. Farr (South Africa) Fetal Alcohol Spectrum disorders: planning health prevention programs

G. Kok (The Netherlands) FASD prevention warranted; implications for interventions

11.00-12.30: parallel 3

THUR PAR-M3) PRETERM NEUROPROTECTION

L. Doyle (Australia) Saving the preterm brain with MgSO4?

P. Gressens (France) Melatonin for neonatal neuroprotection

Petra Hüppi (Switzerland) Epo to protect the preterm brain

Neil Marlow (UK) Postnatal interventions to improve outcomes in high-risk preterm infants

11.00-12.30: parallel 4

THUR PAR-OB3) PREECLAMPSIA

B. Thilaganathan (UK) Types of early and late onset preeclampsia: an integrated model

Stefan R Hansson (Sweden) Micro RNA and fetal hemoglobin in preeclampsia

J. Cornette (The Netherlands) Short & long term cardiovascular outcome after preeclampsia

M. Spaanderman (The Netherlands) Evaluating risk for repeated preeclampsia/HELLP (the Pre Care Study)

Herbert Valensise Therapeutic manipulation of vascular resistance in IUGR/PET

11.00-12.30: parallel 5

THUR PAR-NEO2) NON-INVASIVE VENTILATION

Angela Kribs (Germany) Minimal (pulmonary) handling in the delivery room

Gianluca Lista (Italy) Sustained lung inflation

C.C. Roehr (UK) Rationale of non-invasive ventilation

M. Sanchez Luna (Spain) Non-invasive ventilation in preterm infants

12.30-13.30 LUNCH (Potentially sponsored sessions) and Poster Viewing

13.30-15.00: parallel 1

48) OXYTOCIN AND ATTACHMENT

Angela Siriglu (France) Oxytocin and the brain

Larry Young (USA) Oxytocin and the neurobiology of parenting

Wibke Jonas (Sweden) Variation in oxytocin genes associated with postpartum depression and

breastfeeding

13.30-15.00: parallel 2

THUR PAR-M2) FETAL GROWTH RESTRICTION/IUGR

E. Gratacos (Spain) Stage based management of IUGR

A.L. David (UK) VEGF gene therapy for severe IUGR

C. Lees (UK) Fetal ductus venosus Doppler waveform and infant outcomes

Eva Morsing (Sweden) Long-term outcomes of very preterm IUGR infants

13.30-15.00: parallel 3

THUR PAR-M7) STRATEGIES FOR OPTIMIZING BREASTFEEDING

K. Hedberg Nyqvist (Sweden) Breast-feeding the preterm infant

R. Maastrup (Denmark) Factors associated with exclusive breastfeeding of preterm infants

V. Zanardo (Italy) Lactation after elective CS

F. Dykes (UK) Encouraging breastfeeding: A relational perspective

13.30-15.00: parallel 4

THUR PAR-OB1) PREGNANCIES AND DELIVERIES IN MIGRANT WOMEN

J. Zeitlin (France) Migration to western industrialized countries and perinatal health

R.C. Berg (Norway) Female genital mutilation and obstetric complications

B. Essen (Sweden) Suboptimal care and maternal mortality among foreign-born women in Sweden

D. Ayres-de-Campos (Portugal) Obstetric care in a migrant population with free access to health care

P. Brocklehurst (UK) Ethnic differences in maternal morbidities in the UK

13.30-15.00: parallel 5

THUR PAR-NEO1) OXIDATIVE STRESS AND INFLAMMATION

M. Vento (Spain) Current concepts of oxygen therapy in neonates

O. Dammann (USA) Effect of inflammation on neonatal morbidity and long-term outcome

G. Buonocore (Italy) Oxidative stress in fetal and neonatal diseases

B.W. Kramer (The Netherlands) Effects of chorioamnionitis on the fetus and newborn

15.00-16.30: semi-plenary 1

DPL-OB1) DIABETES AND PREGNANCY- INVENTIONS & INNOVATIONS

O. Koren (Israel) Perinatal programming of GDM – the role of maternal Microbiome

A. Singelaki (UK) Is GDM predictable and preventable in the 1st trimester?

G. H. Visser (The Netherlands) What is the optimal fetal growth?

U. Simeoni (Switzerland) The newborn infant: which mother is it better to be born to? Diabetic, obese,

hypertensive, preterm?

15.00-16.30: semi-plenary 2

DPL-NEO1) LONG-TERM OUTCOMES OF HIGH-RISK INFANTS

Neil Marlow (UK) Are outcomes improving in preterm infants?

Linda de Vries (The Netherlands) What are the long term outcomes of the mildly asphyxiated infants?

Chiara Nosarti (Italy) Adolescent psychiatric problems in individuals born preterm

L. Ibanez (Barcelona) Endocrinology and gynecology of girls and women with LBW

16.30-17.00 Coffee break and poster viewing

17.00-17.30 Key note lecture

PLM2) GENETICS OF PREMATURITY

R. Romero (USA) Genetics of preterm birth and preterm morbidites

17.30-18.25 4 parallel rooms - oral presentation sessions

DAY 3 - Thursday June 17th

8.00-8.55 4 parallel rooms - oral presentation sessions

9.00-10.30 Plenary

PLM7) PERINATAL PROGRAMMING

C.Sibley (UK) Role of the placenta in fetal programming

Rachel Levy (France) Has paternal periconceptional condition an effect on the offspring?

E. Gratacos (Spain) Fetal programming: impact of IUGR

M. Hanson (UK) Periconceptional programming

10.30-11.00 Coffee break and poster viewing

11.00-12.30: parallel 1

FRI PAR-M6) THE CEREBELLUM

Chairpersons: Hüppi/Benders

G. Hesslow (Sweden) Development and function of the cerebellum

L. Ramenghi (Italy) Imaging cerebellar injury

C. Limperopoulos (USA) Cerebellar injury and long-term follow up

11.00-12.30: parallel 2

FRI PAR-M4) FETAL THERAPY

Hecher (Germany) Clinical aspects of TTTS

J. Deprest (Belgium) Laser treatment in TTTS

J. Jani (Belgium) FET procedure in CDH

Thomas Kohl (Germany) In utero treatment of meningomyelocele

Martin Meuli (Switzerland) Open fetal surgery

11.00-12.30: parallel 3

FRI PAR-M5) OPTIMAL TIMING OF UMBILICAL CORD CLAMPING

Therese Dowswell (UK) Maternal aspects on umbilical cord clamping

Ola Andersson (Sweden) Short and long-term effects related to timing of cord clamping in term infants

Heike Rabe (UK) Effects of delayed cord clamping in preterm infants

Nestor Vain (Argentina) The hemodynamics of umbilical cord clamping

Michael Cotton (USA) Rescuing the neonatal brain from hypoxic injury with autologous cord blood

11.00-12.30: parallel 4

FRI PAR-OB2) GDM -TOWARDS A EUROPEAN CONSENSUS

Anil Kapur (India) Health system and societal barriers in improving diabetes related maternal health

Tahir Mahmood (UK) The EBCOG approach (Mahmood is president of EBCOG)

Michael Maresh (UK) The NICE approach

*Elliott Marseille (USA) Assessing the cost-effectiveness of GDM screening and management: the GeDiForCE

Model

E. Nortoft (Denmark) Cost-effectiveness of GDM diagnosis- a national approach

(the GeDiForce Model)

M. Hod (Israel) Towards a Global Consensus; the FIGO Initiative

Discussion

11.00-12.30: parallel 5

FRI PAR-NEO4) BRONCHOPULMONARY DYSPLASIA

C. P. Speer (Germany) Pathogenesis of BPD

E. Baraldi (Italy) BPD and long-term lung function

B. Thebaud (Canada) Stem cells for treatment of BPD

.L Nelin (USA) Clinical management of BPD

12.30-13.30 LUNCH (Potentially sponsored sessions) and Poster Viewing

13.30-14.30 Plenary

PLM4+5) THE OMICS IN PERINATAL MEDICINE

V. Fanos (Italy) Metabolomics in perinatal medicine

O. Koren (Israel) Microbiomics in perinatal medicine

T. Bui (Sweden) Genomics in perinatal medicine

A. Athanasiadis (Greece) Reflection of maternal nutrition in the 2nd trimester amniotic fluid metabolic

profile

14.30-16.00: parallel 1

36) PERINATAL STROKE

E. Saliba (France) Genetic, obstetric and neonatal charact. of infants developing art. ischaemic stroke

M Benders (The Netherlands) Pathogenesis, diagnostics and therapeutic options

Linda de Vries (The Netherlands) Sinovenous thrombosis: Pathogenesis, diagnostics and therapeutic options

Yves Gruel (France) Trombophilia and perinatal stroke

14.30-16.00: parallel 2

PAR-OB5) HOME DELIVERY

J. Nijhuis (The Netherlands) Home deliveries in 2016

A.de Jonge (The Netherlands) Home delivery- is it still safe?

F.A. Chervenak (USA) Planned home birth: the professional responsibility response

14.30-16.00: parallel 3

FRI PAR-M8) PREGNANCY 'ENGINEERING'

U-B Wennerholm (Sweden) Maternal and perinatal outcomes of oocyte donation

François Vialard (France) ART and the long term consequences on the offspring

S. Golombok (UK) Psychosocial effects from reproductive donation

D.Judith (UK) Ethics/Jurisdiction of pregnancy 'engineering'

A. Kalugina (Russia) Obstetric and perinatal outcomes after Transplantation of cryopreserved

ovarian tissue in cancer survivors

14.30-16.00: parallel 4

FRI PAR-OB4) CAN WE PREVENT INTRAUTERINE FETAL DEATH?

Chairperson: Visser

A. Khalil (Jordan) How to identify the 3rd trimester fetus at risk

K. Nicolaides (Greece) How to identify the 3rd trimester fetus at risk

F. Figueras (Spain) How to identify the 3rd trimester fetus at risk

G.C. Smith (UK) Predicting antepartum stillbirth

AE Heasell (UK) Matern. perc. of reduc.fetal movem. is assoc. w. altered placental

structure+function

Discussion

14.30-16.00: parallel 5

FRI PAR-NEO3) DEVELOPMENTAL CARE

Silke Mader (Germany) Family perspectives on neonatal intensive care

Dominique Haumont (Belgium) Family centred NICU care

Susan Ludington-Hoe (UK) Skin-to-skin (KMC) care

N. Conneman (NL) The essence of NIDCAP

G.P. Donzelli (Italy) Narrative medicine in perinatal care

16.00-16.30 Coffee break and poster viewing

16.30-17.30: semi-plenary 1

DPL-OB2) FIRST TRIMESTER RISK ASSESSMENT DEVRIENDT

K. Nicolaides (UK) The place of NT in modern perinatal medicine

G. Makrydimas (Greece) Increased NT implications for the fetus

M. Neyt (Belgium) Economic aspects of NIPT as a national health care service

K. Devriendt (Belgium) Clinical results of NIPT: possibilities and limitations

16.30-17.30: semi-plenary 2

DPL-NEO3) MICROBIOTA

E. Isolauri (Finland) Microbiota hypothesis: impact of the development of gut microbiota

J. Neu (USA) Effect of microbial ecology on the developing brain

17.30-18.25 4 parallel rooms - oral presentation sessions

DAY 4 - Wednesday June 18th

8.00-8.55 4 parallel rooms - oral presentation sessions

9.00-9.30 Plenary

PLM3) PREVENTION AND MANAGEMENT OF PRETERM BIRTH

9.30-10.30: parallel 1

6) MATERNAL DISEASE IN PREGNANCY AND EFFECTS IN THE NEWBORN

E. Özek (Turkey) Thyroid function in pregnancy and neonatal outcomes

I.S. Poromaa (Sweden) Are SSRI safe in pregnancy? Antenatal depression and placental gene expression

Monika Østenson (Norway) Rheumatic diseases in pregnancy

M. Wielgos (Poland) Pregnancy after kidney and liver transplantation: effects on graft, mother and

neonate

9.30-10.30: parallel 2

SAT PAR-M9) PERINATAL ASPHYXIA

Cobi Heijnen (The Netherlands) Mesenchymal stem cells for hypoxic-ischaemic brain injury stem cells

Jan Derks (The Netherlands) Antenatal neuroprotection - an overview

Marianne Thoresen (UK) Hypothermia and beyond

9.30-10.30: parallel 3

SAT PAR-M10) PERINATAL MORTALITY

W. Gyselaers (Belgium) Perinatal audit: should we focus on "mortalities" or "morbidities"?

J. Zeitlin (France) EuroPeristat: epidemiology and European comparisons

A. Mikhailov (Russia) Pregnancy care for prenatally diagnosed lethal fetal abnormalities in singleton and

multiples: medical, ethics and legal aspects

Marina Cuttini (Italy) Ethics from an European perspective

9.30-10.30: parallel 4

PRETERM BIRTH

R. Romero (USA) Does progesterone really works and in which situations?

G. Di Renzo (Italy) European Guidelines on Preterm Labour

E. Özek (Turkey) European RDS Guideline: 2016 update

Angela Kribs (Germany) Gentle transition of the preterm infant

9.30-10.30: parallel 5

SAT PAR-NEO5) OPTIMISING NUTRITION TO PRETERM INFANTS

M. Domellöf (Sweden) Nutritional care of premature infants: microminerals

J.B. van Goudoever (The Netherlands) Which lipids should be administered in preterm infants?

Manon Benders (The Netherlands) Neonatal nutrition, ROP, and brain damage / brain growth

10.30-11.00 Coffee break and poster viewing

11.00-12.00: semi-plenary 1

DPL-OB3) INTRAPARTUM FETAL MONITORING

D. Ayres-de-Campos (Portugal) The new FIGO guidelines on intrapartum fetal monitoring

Austin Ugwumadu (UK) Clinical management in cases of suspected fetal hypoxia/acidosis

Anneke Kwee (The Netherlands) Does CTG+ST improve clinical outcome?

G.H.A. Visser (The Netherlands) The clinical relevance of adjunctive technologies

11.00-12.00: semi-plenary 2

DPL-NEO2) PAIN AND STRESS IN THE NICU

R. Carbajal (France) The burden of pain and stress in the NICU

D. Tibboel (Netherlands) Pain assessment in sick neonates and newborns

K.J. Anand (USA) Neonatal pain management

12.00-12.30: plenary

PLM6) LAST DAY-KEYNOTE LECTURE OF FUTURE PRESIDENT

M. Hod (Israel) Connecting Maternal Medicine to Fetal Medicine- merging of the Perinatal hypotheses

12.30-13.00 Closing ceremony